|
[1]Michielsen PP, Francque SM, Dongen JL.Viral hepatitis and hepa-tocellular carcinoma[J].Wor J Sur Onco, 2005, 3 (27) ∶1477-1494.
|
|
[2]Lu XY, Lee M, Tran T, et al.High level expression of apoptosis in-hibitor in hepatoma cell line expressing hepatitis B virus[J].Int JMed Sci, 2005, 2 (1) ∶30-35.
|
|
[3]董菁, 成军, 杨倩.乙型肝炎病毒新开放读码框架的确定及其意义[J].世界华人消化杂志, 2004, 12 (4) ∶757-762.
|
|
[4]Henkler F, Hoare J, Wasseem N, et al.Intracellular localization ofthe hepatitis B virus HBx protein[J].J Gen virol, 2001, 82 (4) ∶871-882.
|
|
[5]Kim KH, Seong BL.Pro-apoptotic function of HBV X protein ismediated by interaction with c-FLIP and enhancement of death-in-ducing signal[J].EMBO J, 2003, 22 (9) ∶2104-2116.
|
|
[6]Marusawa H, Matsuzawa S, Welsh K, et al.HBXIP functions as acofactor of survivin in apoptosis suppression[J].EMBO J, 2003, 22 (11) ∶2729-2740。
|
|
[7]Tang H, Delgermaa L, Huang F, et al.The transcriptional transac-tion function of HBx protein is important for its augmentation role inHepatitis B virus replication[J].J Virol, 2005, 79 (9) ∶5548-5556.
|
|
[8]Leon B, Taylor L, Vargas M, et al.HBx M130K and V131I (T-A) mutations in HBVgenotype F during a follow-up study in chron-ic carriers[J].Vir J, 2005, 2 (60) ∶1743-1753.
|
|
[9]Kuang SY, Jackson PE, Wang JB, et al.Specific mutations of hepa-titis B virus in plasma predict liver cancer development[J].PNAS, 2004, 1010 (10) ∶3575-3580.
|
|
[10]Li H, Chi CY, Lee S, et al.The mitogenic function of hepatitis Bvirus protein resides within amino acids51-140 and is modulated byN-and C-terminal regulatory regions[J].J Virol, 2006, 80 (21) ∶10554-10564.
|
|
[11]Madden CR, Finegold MJ, Slagle BL.Altered DNAmutation spec-trum in aflatoxin B1-treated transgenic mice that express the hepati-tis B virus X protein[J].J Virol, 2002, 76 (22) ∶11770-11774.
|
|
[12]Bouchard MJ, Sehneider RJ.The Enigmatic X Gene of Hepatitis Bvirus[J].J Virol, 2004, 78 (23) ∶12725-12734.
|
|
[13]Rahmani Z, Huh KW, Lasher R, et al.Hepatitis B virus X proteincolocalizes to mitochondria with a human voltage-dependent anionchannel HVDAC3, and alters its transmembrane potential[J].J Vir-ol, 2000, 74 (6) ∶2840-2846.
|
|
[14]Bergametti F, Sitterlin D, Transy C.Turnover of hepatitis B virus Xprotein is regulated by damaged DNA-binding complex[J].J Virol, 2002, 76 (13) ∶6495-6501.
|
|
[15]Lwa SH, Chen WN.Hepatitis B virus X protein interacts withβ5[J].Vir J, 2005, 2 (76) ∶1743-1750.
|
|
[16]Doria M, Klein N, Lucito R, et al.The hepatitis B virus HBx pro-tein is a dual specificity cytoplasmic activator of Ras and nuclear acti-vator of transcription factors[J].EMBO J, 1995, 14 (19) ∶4747-4757.
|
|
[17]Tarn C, Lee S, Hu Y, et al.Hepatitis B virus X protein differenti-ally activates RAS-RAF-MAPKand JNKpathways in X-transfor-ming versus non-transforming AML 12 hepatocytes[J].J BiolChem, 2001, 276 (37) ∶34671-34680.
|
|
[18]刘亮明, 罗文, 刘晶美, 等.HBx在原发性肝癌发病中的作用及其生物治疗策略[J].世界华人消化杂志, 2005, 13 (4) ∶432-439.
|
|
[19]Sansal I, Sellers WR.The biology and clinical relevance of thePTEN tumor suppressor pathway[J].J Clin Onco, 2004, 22∶2954-2963.
|
|
[20]Chen BC, Wu WT, Ho FM, et al.Inhibition of interleukin-lbeta-induced NF-kappaB activation by calcium/calmodulin-depend-ent protein kinase kinase occurs through Akt activation associatedwith interleukin-1 receptor-associated kinase phosphorylation anduncoupling of MyD88[J].J Biol Chem, 2002, 277 (27) ∶24169-24179.
|
|
[21]Madden CR, Finegold MJ, Slagle BL.Hepatitis B virus x proteinacts as a tumor promoter in development of diethylnitrosamine-in-duced preneoplastic lesions[J].J Virol, 2001, 75 (8) ∶3851-3858.
|
|
[22]Sakurai T, Maeda S, Chang L, et al.Loss of hepatic NF-KB ac-tivity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation[J].PNAS, 2006, 103 (28) ∶10544-10551.
|
|
[23]Nijhara R, Jana SS, Goswami SK, et al.Sustained Activation ofmitogen-activated protein kinases and activator protein1 by the hep-atitis B virus x protein in mouse hepatocytes in vivo[J].J Virol, 2001, 75 (21) ∶10348-10358.
|
|
[24]Bouchard MJ, Wang L, Schneider R.Activation of focal adesionkinase by hepatitis B virus HBx protein:multiple functions in viralreplication[J].J Virol, 2006, 80 (9) ∶4406-4414.
|
|
[25]Barone M, Spano D, Apolito MD, et al.Gene expression analysisin HBV transgenic mouse liver:a model to study early events relatedto hepatocarcinogenesis[J].Mol Med, 2006, 12 (4-6) ∶115-123.
|
|
[26]Elmore L W, Hancock A R, Chang SF, et al.Hepatitis B virus Xprotein and p53 tumor suppressor interactions in the modulation ofapoptosis[J].Proc Natl Acad Sci, 1997, 94∶14707-14712.
|
|
[27]Pan J, Duan LX, Sun BS, et al.Hepatitis B virus X protein pro-tects against anti-Fas-mediated apoptosis in human liver cells byinducing NF-kB[J].J Gen Virol, 2001, 82∶171-182.
|
|
[28]Shih WL, Kuo ML, Chuang SE, et al.Hepatitis B virus X proteininhibits transforming growth factor-β-induced apoptosis throughthe activation of phosphatidylinositol 3-kinase pathway[J].J BiolChem, 2000, 275 (33) ∶25858-25864.
|
|
[29]Shirakata Y, Koike K.Hepatitis B virus X protein induces celldeath by causing loss of mitochondrial membrane potential[J].J BiolChem, 2003, 278 (24) ∶22071-22078.
|
|
[30]Forgues M, Difilippantonio MJ, Linke SP, et al.Involvement ofCrml in hepatitis B virus X protein-induced aberrant centriole repli-cation and abnormal mitotic spindles[J].Mol Cell Biol, 2003, 23 (15) ∶5282-5292.
|
|
[31]Yun C, Cho H, KimSJ, et al.Mitotic aberration coupled with cen-trosome amplification is induced by hepatitis B virus X oncoproteinvia the ras-mitogen-activated protein/extracellular signal-regula-ted kinase-mitogen-actvated protein pathway[J].Mol CancerRes, 2004, 2∶159-169.
|
|
[32]Bouchard M, Giannakopoulos S, Wang EH, et al.Hepatitis B virusHBx protein activation of cyclin A-cyclin dependent kinase 2 com-plexes and G1 transit via a Src kinase pathway[J].J Virol, 2001, 75 (9) ∶4247-4257.
|
|
[33]Park US, Park SK, Lee YI, et al.Hepatitis B virus X protein up-regulates the expression of p21 wafl/cipl and prolongs G1-S transi-tion via a p53-independent pathway in human hepatoma cells[J].Oncogene, 2000, 19∶3384-3394.
|
|
[34]Han HJ, Jung EY, Lee WJ, et al.Cooperative repression of cyclin-dependent kinase inhibitor p21 gene expression by hepatitis B virusX protein and hepatitis C virus core protein[J].FEBS letters, 2002, 518∶169-172.
|
|
[35]Lee S, Tarn C, Wang WH, et al.Hepatitis B virus X protein dif-ferentially regulates cell cycle progression in X-transforming versusnontransforming hepatocyte (AML12) cell lines[J].J Biol Chem, 2002, 277 (10) ∶8730-8740.
|
|
[36]Lara-Pezzi E, Gomez-Gaviro MV, Galvez BG, et al.The hepa-titis B virus X protein promotes tumor cell invasion by inducing mem-brane-type matrix metalloproteinase-1 and cyclooxygenase-2 ex-pression[J].J Clin Inv, 2002, 110 (12) ∶1831-1838.
|
|
[37]Chan CF, Yau TO, Jin DY, et al.Evaluation of nuclear factor-kappa B, urokinase-type plasminogen activator, and HBx and theirclinicopathological significance in hepatocellular carcinoma[J].ClinCancer Res, 2004, 10∶4140-4149.
|
|
[38]Tufan NL, Lian ZR, Liu J, et al.Hepatitis Bx antigen stimulatesexpression of a novel cellular gene, URG4, that promotes hepatocel-lular growth and survival[J].Neoplasia, 2002, 4 (4) ∶355-368.
|
|
[39]Lian ZR, Liu J, Li L, et al.Upregulated expression of a uniquegene by hepatitis Bx antigen promotes hepatocellular growth and tu-morigenesis[J].Neoplasia, 2003, 5 (3) ∶229-244.
|
|
[40]Hwang GY, Lin CY, Huang LM, et al.Detection of the hepatitis Bvirus X protein (HBx) antigen and anti-HBx antibodies in cases ofhuman hepatocellular carcinoma[J].J Clin Micro, 2003, 41 (12) ∶5598-5603.
|
|
[41]Tralhao JG, Roudier J, Morosan S, et al.Paracrine in vivo inhibi-tory effects of hepatitis B virus X protein (HBx) on liver cell prolifer-ation:An alternative mechanism of HBx-related pathogenesis[J].PNAS, 2002, 99 (1) ∶6991-6996.
|
|
[42]Han JQ, Ding LH, Yuan B, et al.Hepatitis B virus X protein andthe estrogen receptor variant lacking exon 5 inhibit estrogen receptorsignaling in hepatoma cells[J].Nucleic Acids Res, 2006, 34 (10) ∶3095-3106.
|
PDF下载 ( 141 KB)
本文二维码
下载:
